Stay updated on Pembrolizumab in NSCLC with PS 2 Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in NSCLC with PS 2 Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, indicating a backend/template update. No changes to the study text or user-facing elements are implied by this revision.
    Difference
    0.0%
    Check dated 2026-07-03T21:44:00.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.0 to v3.6.2, indicating a newer revision of the page content.
    Difference
    0.0%
    Check dated 2026-06-26T23:47:24.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now shows 'No longer looking for participants' under enrollment and adds new sections for How to Read a Study Record, Common Questions, and How to Join a Study. It also updates the Intervention/Treatment label formatting and includes a Revision: v3.6.0 tag.
    Difference
    0.4%
    Check dated 2026-06-12T16:43:57.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.5.5, indicating a small update to the site, with no visible changes to the study information.
    Difference
    0.1%
    Check dated 2026-06-05T12:33:40.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision: v3.5.4 has been added, replacing Revision: v3.5.3. This change updates the page's version metadata rather than its visible content or behavior.
    Difference
    0.1%
    Check dated 2026-05-15T05:51:39.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page’s UI/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a backend or display release rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:14:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in NSCLC with PS 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.